Servizio Comunitario di Informazione in materia di Ricerca e Sviluppo - CORDIS

The development of a novel therapeutic vaccine for the selective treatment of the autoimmune disorder, Graves’ disease

Dal 2013-12-01 al 2018-06-30, progetto in corso | DAVIAD Sito web

Dettagli del progetto

Costo totale:

EUR 8 362 660,60

Contributo UE:

EUR 5 924 893

Coordinato in:

Belgium

Invito a presentare proposte:

FP7-HEALTH-2013-INNOVATION-1See other projects for this call

Meccanismo di finanziamento:

CP-FP - Small or medium-scale focused research project

Obiettivo

Coordinatore

APITOPE INTERNATIONAL NV
Belgium

Contributo UE: EUR 3 539 839,50


AGORALAAN A BIS
3590 DIEPENBEEK
Belgium
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contatto amministrativo: Luc Lammens
Tel.: +32 499 52 54 52
Fax: +32 11 28 69 09
E-mail

Partecipanti

QUINTILES BENEFIT FRANCE INC
France

Contributo UE: EUR 885 609


RUE MAURICE RAVEL 3/5
92594 LEVALLOIS PERRET CEDEX
France
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contatto amministrativo: Gary Johnson
Tel.: +33 450449465
Fax: +33 450449465
E-mail
KWS BIOTEST LIMITED
United Kingdom

Contributo UE: EUR 1 484 683,50


MEDICAL SCIENCES BUILDING UNIVERSITY WALK
BS8 1TD BRISTOL
United Kingdom
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contatto amministrativo: Neil Williams
Tel.: +44 1179287886
Fax: +44 1179287896
E-mail
GlaxoSmithKline Biologicals
Partecipazione terminata
Belgium

Contributo UE: EUR 14 761


Rue de l'Institut 89
1330 Rixensart
Belgium
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contatto amministrativo: Philippe Denoel
Tel.: +3226564032
E-mail

Argomenti

Life Sciences